Evidence map›Paper›PMID 12925687›Full record

ReviewThe Journal of clinical investigation2003

The potential for gene repair via triple helix formation.

Michael M Seidman, Peter M Glazer

Abstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Divalent counterion-induced condensation of triple-strand DNA.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  16. Article
  17. Article
  18. DNA interstrand crosslink repair in mammalian cells: step by step.Critical reviews in biochemistry and molecular biology · 2010
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michael M SeidmanDepartment of Therapeutic Radiology, Yale University School of Medicine, P.O. Box 208040, New Haven, Connecticut 06520-8040, USA.
Peter M Glazer

Funding

TARGETED MUTAGENESIS OF DNA VIA TRIPLE HELIX FORMATIONR01CA064186 · NCI · YALE UNIVERSITY · PI GLAZER, PETER M · 1995 to 2008
$2.6M
Gene Targeting Mediated By Triple Helix Forming OligonucleotidesZ01AG000738 · NIA · NATIONAL INSTITUTE ON AGING · PI SEIDMAN, MICHAEL M · 1999 to 2008
$1.4M
RECOMBINATION INDUCED BY TRIPLEX TARGETED DNA DAMAGER01GM054731 · NIGMS · YALE UNIVERSITY · PI GLAZER, PETER M · 1997 to 2004
$1.4M
NCI NIH HHS CA64186NCI NIH HHS R01 CA064186NIGMS NIH HHS GM54731NIGMS NIH HHS R01 GM054731
6 · The paper itself

Abstract

Triplex-forming oligonucleotides (TFOs) can bind to polypurine/polypyrimidine regions in DNA in a sequence-specific manner. The specificity of this binding raises the possibility of using triplex formation for directed genome modification, with the ultimate goal of repairing genetic defects in human cells. Several studies have demonstrated that treatment of mammalian cells with TFOs can provoke DNA repair and recombination, in a manner that can be exploited to introduce desired sequence changes. This review will summarize recent advances in this field while also highlighting major obstacles that remain to be overcome before the application of triplex technology to therapeutic gene repair can be achieved.

Indexed as

DNADNA RepairGenetic TherapyRecombination, GeneticAnimalsGenetic TechniquesModels, ChemicalDNAtriplex DNA

Identifiers

PMID12925687
PMCPMC171401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.